CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring ...
Tempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECG-Low ...
Remote Diagnostic Technologies Ltd. (RDT), an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham.
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, ...
RDT, a leading provider of pre-hospital care solutions, will be previewing its Tempus ALS™ defibrillator monitor at MEDICA 2016. Visitors to Stand D70 in Hall 11 will be able to see this innovative ...
Tempus AI, Inc. and Predicta Biosciences recently expanded the commercial rollout of their co-branded GenoPredicta™ whole-genome sequencing assay, which combines flow cytometry and ultra-sensitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results